Evidence map›Paper›PMID 37360582›Full record

ArticleEuropean economic review2023

The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries.

Elizaveta Archanskaia, Erik Canton, Alexandr Hobza, Plamen Nikolov, Wouter Simons

Abstract read
In one paragraph

Article in European economic review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elizaveta ArchanskaiaEuropean Commission, Directorate-General for Economic and Financial Affairs, 170 Rue de la Loi, Brussels, 1049, Belgium.
Erik CantonEuropean Commission, Directorate-General for Economic and Financial Affairs, 170 Rue de la Loi, Brussels, 1049, Belgium.
Alexandr HobzaEuropean Commission, Directorate-General for Economic and Financial Affairs, 170 Rue de la Loi, Brussels, 1049, Belgium.
Plamen NikolovEuropean Commission, Directorate-General for Economic and Financial Affairs, 170 Rue de la Loi, Brussels, 1049, Belgium.
Wouter SimonsEuropean Commission, Directorate-General for Economic and Financial Affairs, 170 Rue de la Loi, Brussels, 1049, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper assesses corporate financial distress in terms of liquidity and risk of insolvency due to the COVID-19 pandemic. We develop a novel multivariate approach to obtain monthly data on industry turnover, exploiting real time data to capture the atypical character of industry-specific disturbances. By combining the estimated set of industry revenue shocks with pre-pandemic financial statements, we quantify the impact of the pandemic on the risk of insolvency in the EU non-financial corporate sector. Our definition of risk of insolvency takes into account not only the equity position of firms, but also risks relating to overindebtedness. The analysis controls for firms that were financially vulnerable already before the pandemic, thus being prone to become at risk of insolvency also in absence of the COVID-19 turmoil. We find that, for the EU as a whole, 25% of firms exhausted their liquidity buffers by the end of 2021 (a practical cut-off date of the analysis, not an assumed end of the pandemic). Furthermore, 10% of firms which were viable before the pandemic, appear to have shifted into risk of insolvency as a result of the COVID-19 crisis. The magnification of financial vulnerability in the hardest-hit industries mainly occurs among firms with no legacy issues, i.e. firms with positive profitability pre-pandemic. A similar finding is reported for some of the hardest-hit countries, such as Italy and Spain. In other countries, such as Germany or Greece, the magnification of financial vulnerability mainly occurs among firms with negative profitability pre-pandemic.

Indexed as

COVID-19financial distressinsolvencyliquiditynon-financial corporate sectornowcastingprofitability

Identifiers

PMID37360582
PMCPMC10251726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.